Skip to Main Content

Paper Details

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Blood Adv
9
2023
Author NameAffiliation
Hiroko TanakaTokyo Medical and Dental University
Hiroshi HandaGunma University
Satoru MiyanoTokyo Medical and Dental University
Seishi OgawaGraduate School of Medicine, Kyoto University
Seishi OgawaCenter for Hematology and Regenerative Medicine, Karolinska Institute
Seishi OgawaInstitute for the Advanced Study of Human Biology, Kyoto University
  • 1 - 6

Datasets

Release 1.2